Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded a Generalized pustular psoriasis entry and a new Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision banner updated from v3.4.1 to v3.4.2, reflecting an internal software update.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedThe changes involve UI controls for glossary visibility and minor capitalization/version label updates, which do not alter the study information or participant experience. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.